ETTX
Entasis Therapeutics Holdings Inc.
Clarus Lifesciences Iii, L.P. bought $6.8M of Entasis Therapeutics Holdings Inc.
10% owner
Bought$6,800,925
$15.00Price
453,395Shares
+39%Stake
What ETTX did for a copier
Prices for ETTX after this filing aren't in yet.
Clarus Lifesciences Iii, L.P.'s record
4 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Sep 28. Filed Tue, Oct 2. Not investment advice.